95 related articles for article (PubMed ID: 21840308)
41. [Inhibitory effects of cyclooxygenase-2 inhibitor celecoxib on growth and angiogenesis of human liver cancer HepG2 cell xenografts in small nude mice].
Zuo CH; Li ZR; Zhou X; Ouyang YZ; Zhou ZY; Zeng L
Ai Zheng; 2006 Apr; 25(4):414-20. PubMed ID: 16613672
[TBL] [Abstract][Full Text] [Related]
42. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
43. [Anti-tumor effect of eukaryotic expressing plasmid containing soluble tumor necrotic factor-related apoptosis inducing ligand combined with human angiostatin Kringle (1 - 3) genes on human gastric cancer xenografts in nude mice].
Sun W; Jiang Z; Xiang TX; Tao XH; Huang AL; Wang PL
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):841-5. PubMed ID: 19595126
[TBL] [Abstract][Full Text] [Related]
44. Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.
Ciardiello F; Bianco R; Damiano V; Fontanini G; Caputo R; Pomatico G; De Placido S; Bianco AR; Mendelsohn J; Tortora G
Clin Cancer Res; 2000 Sep; 6(9):3739-47. PubMed ID: 10999768
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of vascular endothelial growth factor expression in keloid fibroblasts by vector-mediated vascular endothelial growth factor shRNA: a therapeutic potential strategy for keloid.
Zhang GY; Yi CG; Li X; Zheng Y; Niu ZG; Xia W; Meng Z; Meng CY; Guo SZ
Arch Dermatol Res; 2008 Apr; 300(4):177-84. PubMed ID: 18239926
[TBL] [Abstract][Full Text] [Related]
46. RNAi and tumor angiogenesis: bridging the gap towards anti-cancer therapy?
Dave RS
Leuk Res; 2007 Apr; 31(4):421-2. PubMed ID: 17157908
[No Abstract] [Full Text] [Related]
47. A small interfering CD147-targeting RNA inhibited the proliferation, invasiveness, and metastatic activity of malignant melanoma.
Chen X; Lin J; Kanekura T; Su J; Lin W; Xie H; Wu Y; Li J; Chen M; Chang J
Cancer Res; 2006 Dec; 66(23):11323-30. PubMed ID: 17145878
[TBL] [Abstract][Full Text] [Related]
48. Suppression of survivin expression inhibits in vivo tumorigenicity and angiogenesis in gastric cancer.
Tu SP; Jiang XH; Lin MC; Cui JT; Yang Y; Lum CT; Zou B; Zhu YB; Jiang SH; Wong WM; Chan AO; Yuen MF; Lam SK; Kung HF; Wong BC
Cancer Res; 2003 Nov; 63(22):7724-32. PubMed ID: 14633697
[TBL] [Abstract][Full Text] [Related]
49. VEGF-targeted short hairpin RNA inhibits intraperitoneal ovarian cancer growth in nude mice.
Bai Y; Deng H; Yang Y; Zhao X; Wei Y; Xie G; Li Z; Chen X; Chen L; Wang Y; Su D; Qian Z; Zhong Q; Luo H; Yi T
Oncology; 2009; 77(6):385-94. PubMed ID: 20130421
[TBL] [Abstract][Full Text] [Related]
50. [Preliminary effect of VEGF promoter-driven recombinant adenovirus containing double suicide genes on apoptosis of human gastric carcinoma cells].
Kong H; Huang ZH; Li Z; Yu JL; Chen HJ; Han XJ
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1152-5, 1160. PubMed ID: 17715013
[TBL] [Abstract][Full Text] [Related]
51. Antisense to cyclin D1 inhibits vascular endothelial growth factor-stimulated growth of vascular endothelial cells: implication of tumor vascularization.
Yasui M; Yamamoto H; Ngan CY; Damdinsuren B; Sugita Y; Fukunaga H; Gu J; Maeda M; Takemasa I; Ikeda M; Fujio Y; Sekimoto M; Matsuura N; Weinstein IB; Monden M
Clin Cancer Res; 2006 Aug; 12(15):4720-9. PubMed ID: 16899623
[TBL] [Abstract][Full Text] [Related]
52. Vesnarinone inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing the expression of vascular endothelial growth factor and interleukin-8.
Harada K; Supriatno ; Yoshida H; Sato M
Int J Oncol; 2005 Dec; 27(6):1489-97. PubMed ID: 16273203
[TBL] [Abstract][Full Text] [Related]
53. [Adenovirus-mediated double suicide gene selectively kills breast cancer MCF-7 cells in vitro].
Kong H; Huang ZH; Li Q; Yang LC; Yu JL; Li Z
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):907-10. PubMed ID: 18583225
[TBL] [Abstract][Full Text] [Related]
54. RNAi-mediated gene silencing of vascular endothelial growth factor inhibits growth of colorectal cancer.
Lv W; Zhang C; Zhou DH; Hao J; Sun JG; Liu T; Hao YX; Yu PW
Cancer Biother Radiopharm; 2007 Dec; 22(6):841-52. PubMed ID: 18158776
[TBL] [Abstract][Full Text] [Related]
55. Tissue specific expression of suicide genes delivered by nanoparticles inhibits gastric carcinoma growth.
Liu T; Zhang G; Chen YH; Chen Y; Liu X; Peng J; Xu MH; Yuan JW
Cancer Biol Ther; 2006 Dec; 5(12):1683-90. PubMed ID: 17224635
[TBL] [Abstract][Full Text] [Related]
56. Chitosan/VEGF-sIRNA nanoparticle for gene silencing.
Yang Y; Liu X; Zhang D; Yu W; Lv G; Xie H; Zheng J; Ma X
J Control Release; 2011 Nov; 152 Suppl 1():e160-1. PubMed ID: 22195822
[No Abstract] [Full Text] [Related]
57. Combined effect of sCD40L and PI3K siRNA on transplanted tumours growth and microenvironment in nude mice with gastric cancer.
Li R; Chen WC; Pang XQ; Tian WY; Wang WP; Zhang XG
Mol Biol Rep; 2012 Sep; 39(9):8755-61. PubMed ID: 22736104
[TBL] [Abstract][Full Text] [Related]
58. Construction of a novel vector expressing Survivin-shRNA and fusion suicide gene yCDglyTK and its application in inhibiting proliferation and migration of colon cancer cells.
Ye L; Yang Y; Ma XY; Li D; Xu ML; Tan P; Long LM; Wang HQ; Liu T; Guo YH
Exp Ther Med; 2017 Nov; 14(5):4721-4728. PubMed ID: 29201172
[TBL] [Abstract][Full Text] [Related]
59. Construction of a novel vector expressing the fusion suicide gene yCDglyTK and hTERT-shRNA and its antitumor effects.
Li J; Zhang G; Liu T; Gu H; Yan L; Chen B
Exp Ther Med; 2012 Sep; 4(3):442-448. PubMed ID: 23181115
[TBL] [Abstract][Full Text] [Related]
60. Cover story. RNA interference (RNAi).
Park TG
J Control Release; 2008 Jul; 129(2):75. PubMed ID: 18547671
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
